Monica Holmberg, PharmD, BCPS, is a pharmacist in Phoenix, Arizona, and a Pharmacy Times contributor.
Seattle Genetics, Inc's Adcetris
December 5th 2011The FDA has granted accelerated approval to Seattle Genetics, Inc's Adcetris (brentuximab vedotin). Adcetris is indicated for the treatment of Hodgkin lymphoma (HL) after failure of autologous stem cell transplant (ASCT) or after failure of at least 2 prior multiagent chemotherapy regimens in patients who are not candidates for ASCT.
Read More
Rx Product News Profile: A Closer Look at New FDA Actions: Centocor Ortho Biotech's Stelara
February 16th 2010The FDA recently approved Centocor Ortho Biotech's Stelara (ustekinumab)for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Read More